Monocyte tissue factor induction by activation of β2-glycoprotein-I- specific T lymphocytes is associated with thrombosis and fetal loss in patients with antiphospholipid antibodies

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2258-2262

  Visvanathan, S ^a   Geczy, C L ^a   Harmer, J A ^a   McNeil, H P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOLIPID ANTIBODY; THROMBOPLASTIN;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; FEMALE; FETUS WASTAGE; HUMAN; LIPOPROTEIN SECRETION; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS;

EID: 0034663948     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2258     Document Type: Article

References (19)

1. Immunology and clinical importance of antiphospholipid antibodies
2. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β-glycoprotein I (apolipoprotein H)
3. The management of thrombosis in the antiphospholipid-antibody syndrome
4. 2-glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome
5. Thrombosis, recurrent fetal loss, and thrombocytopenia: Predictive value of the anticardiolipin antibody test
6. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis
7. Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus
8. 2- glycoprotein I antibodies in antiphospholipid syndrome: A comparative study with anticardiolipin antibodies
9. 2-glycoprotein I: A specific marker for the antiphospholipid syndrome
10. Immunology of the antiphospholipid antibody syndrome
11. 2-glycoprotein 1 in patients with the antiphospholipid syndrome
12. Cellular mechanisms for the activation of blood coagulation
13. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
14. Thrombosis in primary antiphospholipid syndrome: A pivotal role for monocyte tissue factor expression
15. New fluorogenic substrates for α-thrombin, factor Xa, kallikreins, and urokinase
16. Delayed hypersensitivity in man: Effects of systemic anticoagulation
17. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes
18. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?
19. Th1-type immunity is incompatible with successful pregnancy